Clinical Department, HemoClear BV, Zwolle, The Netherlands.
Department of Blood Cell Research, Sanquin Research, Amsterdam, The Netherlands.
Transfus Med. 2022 Feb;32(1):53-63. doi: 10.1111/tme.12830. Epub 2021 Nov 10.
Our objectives were to determine the separation characteristics and blood product quality of a gravity-driven microfiltration blood separation system (HemoClear, The Netherlands).
A range of centrifugal blood separation devices, including intraoperative cell salvage devices (cell savers) and apheresis machines, are available to assist in preparing both allogenic and autologous blood products. These devices are expensive to operate and require extensive training.
Nine whole blood units were collected under standard conditions and analysed for haematological parameters, thromboelastographic properties, platelet morphology and activation, and red blood cell (RBC) deformability and morphology. Three whole blood units were separated by means of the HemoClear device, into a liquid and cellular component. The cellular component was diluted with SAGM and cold stored for 14 days. To simulate cell salvage six whole blood units were diluted with isotonic saline, followed by multiple HemoClear separation rounds.
The recovery of both RBCs (100 ± 1.6%) and white blood cells (99 ± 4.5%) after undiluted filtration were very high, while platelet recovery was high (83 ± 3.0%). During the filtration, and cold storage after filtration storage both the non-deformable RBC fraction and the RBC maximum elongation remained stable. Parameters of thromboelastography indicated that platelets remain functional after filtration and after 7 days of cold storage. In the cell salvage simulation the total protein load in the cellular fraction was reduced by 65 ± 4.1% after one washing round and 84 ± 1.9% after two consecutive washing rounds.
The novel blood filter studied effectively separates whole blood into diluted plasma and platelet-rich RBCs. Moreover, the device effectively washed diluted whole blood, driving over 80% of proteins to the liquid component.
我们的目的是确定重力驱动的微滤血液分离系统(荷兰 HemoClear)的分离特性和血液产品质量。
有一系列离心血液分离设备,包括术中细胞回收装置(细胞保存器)和血浆分离机,可用于辅助制备同种异体和自体血液产品。这些设备操作昂贵,需要广泛的培训。
在标准条件下采集 9 个全血单位,并分析血液学参数、血栓弹性图特性、血小板形态和激活以及红细胞(RBC)变形性和形态。使用 HemoClear 设备将 3 个全血单位分离成液体和细胞成分。将细胞成分用 SAGM 稀释并冷藏 14 天。为了模拟细胞回收,将 6 个全血单位用等渗盐水稀释,然后进行多次 HemoClear 分离循环。
未稀释过滤后 RBC(100±1.6%)和白细胞(99±4.5%)的回收率非常高,而血小板回收率也很高(83±3.0%)。在过滤过程中和过滤后冷藏期间,非变形 RBC 部分和 RBC 最大伸长率保持稳定。血栓弹性图参数表明,过滤后和冷藏 7 天后血小板仍具有功能。在细胞回收模拟中,经过一轮洗涤后,细胞部分的总蛋白负荷减少了 65±4.1%,经过连续两轮洗涤后减少了 84±1.9%。
研究中新型血液过滤器可有效地将全血分离为稀释的血浆和富含血小板的 RBC。此外,该设备可有效地洗涤稀释的全血,将超过 80%的蛋白质驱赶到液体部分。